Visit to Japan January 2023

LOVOT

Professor Birthe Dinesen had a visit to Tokyo and JD TeleTech January 23-28 2023.

It was the first time after the COVID-19 pandemic that Dr Dinesen had a visit to Japan.

The aim of the visit was to meet with current collaborators and to establish new collaborators within JD TeleTech.

Thank you to Rumi at the Danish Embassy in Tokyo for help organizing the visits to the companies and other partners.

Visit Groove-X
Juntendo University

April 25 the JD TeleTech will have a round table at Jutendo University Hospital in Tokyo. Please stay turned on this webpage about more details.

LOVOT calls for joy and smiles for elderly with dementia

LOVOT

LOVOT is a social robot developed by Groove X in Japan. In March Laboratory for Welfare Technologies was about to begin to test the LOVOT with citizens with dementia at nursing homes in Aalborg, Viborg and Skive Municipality in Denmark as the first place in the world. LOVOT was brought to the nursing homes and ready to interact with the citizens. Unfortunately, Covid-19 started spreading, causing Denmark to go into lockdown and stopped us from testing LOVOT at the nursing homes. This has brought us in quite a unique situation: LOVOT being in lockdown together with citizens with dementia at the nursing homes. We are therefore excited to see how LOVOT will interact with the citizens in a lockdown period. The nursing homes now report back that the citizens have enjoyed the LOVOT and it has created joy and a lot of smiles for the citizens with dementia. We have postponed our scientific test supported by the National Health Authorities (Sundhedsstyrelsen) in Denmark to the fall 2020.

LOVOT has arrived

LOVOT – a new social robot from Groove X in Japan has arrived to Aalborg University.

The LOVOTs are named Anne and Lars and will be tested for the first time outside Japan in interaction with citizens with dementia this spring in collaboration with Aalborg, Viborg and Skive Municipalities.

The LOVOTs are designed to create joy, has memory (AI), remember people, recognizes own name and has unique personalities that develops over time.

The National Health Authorities in Denmark are funding the project.

New PHD study focusing on critical IoT application in the Future Patient project

The scope of the Ph.D. project covers the evaluation of the use of Low Power Wide Area Network (LPWAN) technologies for the mission-critical Internet of Things (IoT) applications (Remote healthcare, traffic safety & control, smart grid automation, etc.). Unlike in the case of massive IoT applications, Critical IoT applications have more strict requirements for network performance such as higher level of security, high resiliency, low latency, scalability, and interoperability with existing communication systems.

The goal of the project is to do a thorough investigation of all the available communication technologies from an end to end perspective. The idea here is to identify which of the technology or combination of technologies that are cable of supporting all the needs of critical IoT applications.

The project also involves investigation the current infrastructure and either suggesting changes to it or proposing a new network architecture that is cable of transferring critical data more reliably and securely through the network. This part of the project involves working closely with other universities in Denmark and Japan, and Industrial partners to implement and test some of the upcoming wireless technologies for critical IoT application.

To begin with, the project includes collaboration with the Department of Health Science and Technology at Aalborg University on Future patient project. The project will primarily focus on real-time monitoring of patient’s data using the IoT technologies.

New grant for the continuation of Future Patient

We have just received a grant of 5 million kroner for the continuation of Future Patient – telerehabilitation of cardiac patients. We will work on preparing an implementation of the project, and adapt the Hjerteportalen.dk to rehabilitation of atrial fibrillation patients.

We are looking forward to the next steps in the process, and would like to thank the Aage og Johanne Louis Hansens Foundation for the support.